Literature DB >> 22083158

Role of uncoupled endothelial nitric oxide synthase in abdominal aortic aneurysm formation: treatment with folic acid.

Ling Gao1, Kin L Siu, Karel Chalupsky, Andrew Nguyen, Peng Chen, Neal L Weintraub, Zorina Galis, Hua Cai.   

Abstract

It has been shown that endothelial NO synthase (eNOS) uncoupling occurs in hypertension and atherosclerosis. However, its causal role in vascular pathogenesis has not been characterized previously. Here, we challenged eNOS preuncoupled hyperphenylalaninemia (hph)-1 mice (deficient in eNOS cofactor tetrahydrobiopterin biosynthetic enzyme GTPCHI) with angiotensin II (Ang II; 0.7 mg/kg per day, 14 days). Both wild-type and hph-1 groups developed hypertension similarly up to day 6 to 7. Thereafter, ≈14% of Ang II-infused (0.7 mg/kg per day) hph-1 mice (n=72) started to die suddenly of ruptured abdominal aortic aneurysm (AAA). Among the survivors, 65% developed AAA, resulting in a total morbidity rate of 79%. In contrast, none of the Ang II-infused wild-type mice died or developed AAA. Ang II progressively deteriorated eNOS uncoupling in hph-1 mice while augmenting tetrahydrobiopterin and nitric oxide (NO(·)) deficiencies. The abundance of the tetrahydrobiopterin salvage enzyme dihydrofolate reductase in the endothelium was decreased in hph-1 mice and further diminished by Ang II infusion. Intriguingly, restoration of dihydrofolate reductase expression by oral administration of folic acid or overexpression of dihydrofolate reductase completely prevented AAA formation in Ang II-infused hph-1 mice while attenuating progressive uncoupling of eNOS. Folic acid also attenuated vascular remodeling and inflammation characterized by medial elastin breakdown and augmented matrix metalloproteinase 2 activity and activation of matrix metalloproteinase 9, as well as macrophage infiltration. In conclusion, these data innovatively suggest a causal role of eNOS uncoupling/tetrahydrobiopterin deficiency in AAA formation. Therefore, oral folic acid administration, endothelium-targeted dihydrofolate reductase gene therapy, and perhaps other countermeasures directed against eNOS uncoupling could be used as new therapeutics for AAA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22083158      PMCID: PMC3668799          DOI: 10.1161/HYPERTENSIONAHA.111.181644

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  38 in total

1.  Regulation of the mitochondrial permeability transition by matrix Ca(2+) and voltage during anoxia/reoxygenation.

Authors:  P Korge; H M Honda; J N Weiss
Journal:  Am J Physiol Cell Physiol       Date:  2001-03       Impact factor: 4.249

2.  Oxidative stress is involved in the development of experimental abdominal aortic aneurysm: a study of the transcription profile with complementary DNA microarray.

Authors:  Noriyuki Yajima; Masahisa Masuda; Masaru Miyazaki; Nobuyuki Nakajima; Shu Chien; John Y-J Shyy
Journal:  J Vasc Surg       Date:  2002-08       Impact factor: 4.268

3.  Flow loading induces macrophage antioxidative gene expression in experimental aneurysms.

Authors:  Takeshi K Nakahashi; Katsuyuki Hoshina; Philip S Tsao; Eiketsu Sho; Mien Sho; John K Karwowski; Cory Yeh; Ruey-Bing Yang; James N Topper; Ronald L Dalman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-12-01       Impact factor: 8.311

4.  Folic acid reverts dysfunction of endothelial nitric oxide synthase.

Authors:  E S Stroes; E E van Faassen; M Yo; P Martasek; P Boer; R Govers; T J Rabelink
Journal:  Circ Res       Date:  2000-06-09       Impact factor: 17.367

5.  Matrix metalloproteinase-2 and -9 differentially regulate smooth muscle cell migration and cell-mediated collagen organization.

Authors:  Chad Johnson; Zorina S Galis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-10-09       Impact factor: 8.311

6.  Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms.

Authors:  G Matthew Longo; Wanfen Xiong; Timothy C Greiner; Yong Zhao; Nicola Fiotti; B Timothy Baxter
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

Review 7.  The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases.

Authors:  Hua Cai; Kathy K Griendling; David G Harrison
Journal:  Trends Pharmacol Sci       Date:  2003-09       Impact factor: 14.819

8.  Congenic mapping and genotyping of the tetrahydrobiopterin-deficient hph-1 mouse.

Authors:  Jeffrey P Khoo; Taija Nicoli; Nicholas J Alp; Janice Fullerton; Jonathan Flint; Keith M Channon
Journal:  Mol Genet Metab       Date:  2004-07       Impact factor: 4.797

9.  Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension.

Authors:  Ulf Landmesser; Sergey Dikalov; S Russ Price; Louise McCann; Tohru Fukai; Steven M Holland; William E Mitch; David G Harrison
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

10.  Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice.

Authors:  Nicholas J Alp; Martina A McAteer; Jeffrey Khoo; Robin P Choudhury; Keith M Channon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-01-05       Impact factor: 8.311

View more
  52 in total

1.  Reply: To PMID 25882860.

Authors:  Qiang Li; Ji-Youn Youn; Shan Li; Hua Cai
Journal:  J Hypertens       Date:  2015-11       Impact factor: 4.844

2.  Novel Treatment of Hypertension by Specifically Targeting E2F for Restoration of Endothelial Dihydrofolate Reductase and eNOS Function Under Oxidative Stress.

Authors:  Hong Li; Qiang Li; Yixuan Zhang; Wenting Liu; Bo Gu; Taro Narumi; Kin Lung Siu; Ji Youn Youn; Peiqing Liu; Xia Yang; Hua Cai
Journal:  Hypertension       Date:  2019-01       Impact factor: 10.190

3.  Netrin-1 abrogates ischemia/reperfusion-induced cardiac mitochondrial dysfunction via nitric oxide-dependent attenuation of NOX4 activation and recoupling of NOS.

Authors:  Kin Lung Siu; Christopher Lotz; Peipei Ping; Hua Cai
Journal:  J Mol Cell Cardiol       Date:  2014-07-24       Impact factor: 5.000

4.  Circulating tetrahydrobiopterin as a novel biomarker for abdominal aortic aneurysm.

Authors:  Kin Lung Siu; Hua Cai
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-09-26       Impact factor: 4.733

Review 5.  Surviving With Smog and Smoke: Precision Interventions?

Authors:  Hua Cai; Chen Wang
Journal:  Chest       Date:  2017-07-08       Impact factor: 9.410

6.  Endothelial Cell Tetrahydrobiopterin Modulates Sensitivity to Ang (Angiotensin) II-Induced Vascular Remodeling, Blood Pressure, and Abdominal Aortic Aneurysm.

Authors:  Surawee Chuaiphichai; Victoria S Rashbrook; Ashley B Hale; Lucy Trelfa; Jyoti Patel; Eileen McNeill; Craig A Lygate; Keith M Channon; Gillian Douglas
Journal:  Hypertension       Date:  2018-05-29       Impact factor: 10.190

7.  Inflammatory monocytes determine endothelial nitric-oxide synthase uncoupling and nitro-oxidative stress induced by angiotensin II.

Authors:  Sabine Kossmann; Hanhan Hu; Sebastian Steven; Tanja Schönfelder; Daniela Fraccarollo; Yuliya Mikhed; Melanie Brähler; Maike Knorr; Moritz Brandt; Susanne H Karbach; Christian Becker; Matthias Oelze; Johann Bauersachs; Julian Widder; Thomas Münzel; Andreas Daiber; Philip Wenzel
Journal:  J Biol Chem       Date:  2014-08-20       Impact factor: 5.157

8.  Prevention of abdominal aortic aneurysm by anti-microRNA-712 or anti-microRNA-205 in angiotensin II-infused mice.

Authors:  Chan Woo Kim; Sandeep Kumar; Dong Ju Son; In-Hwan Jang; Kathy K Griendling; Hanjoong Jo
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-05-08       Impact factor: 8.311

Review 9.  Reactive oxygen species: key regulators in vascular health and diseases.

Authors:  Qishan Chen; Qiwen Wang; Jianhua Zhu; Qingzhong Xiao; Li Zhang
Journal:  Br J Pharmacol       Date:  2017-07-11       Impact factor: 8.739

10.  Nifedipine attenuation of abdominal aortic aneurysm in hypertensive and non-hypertensive mice: Mechanisms and implications.

Authors:  Xiao Niu Miao; Kin Lung Siu; Hua Cai
Journal:  J Mol Cell Cardiol       Date:  2015-08-04       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.